DKSH

JANSSEN-CILAG LTD

Featured products of Janssen-Cilag
erdafitinib
Packing/Price
2 × 42's2 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erdafitinib
Packing/Price
1 × 14's2 × 28's1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erdafitinib
Packing/Price
1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
daratumumab, hyaluronidase
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
apalutamide
Packing/Price
120's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BB05 - apalutamide : Belongs to the class of anti-androgens. Used in treatment of neoplastic diseases.
ibrutinib
Packing/Price
1 × 120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
ibrutinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
amivantamab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX18 - amivantamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Distributed by DKSH
erdafitinib
Packing/Price
2 × 42's2 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erdafitinib
Packing/Price
1 × 14's2 × 28's1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erdafitinib
Packing/Price
1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
daratumumab, hyaluronidase
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
apalutamide
Packing/Price
120's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BB05 - apalutamide : Belongs to the class of anti-androgens. Used in treatment of neoplastic diseases.
ibrutinib
Packing/Price
1 × 120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
ibrutinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
amivantamab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX18 - amivantamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in